Position in MRNA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$408,850,845
+$170,518,270 QoQ
Shares Held
8,048,245
-0.4% QoQ
Ownership
2.03%
of shares outstanding
% of Portfolio
27.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Derivatives in MRNA
reported options exposure · as of Sep 30, 2024CallValue
$532,768
CallShares
7,972
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Theleme Partners LLP holds $408,850,845 across 1 Biotechnology name. MRNA ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
This page
|
8,048,245 | $408,850,845 |
All Filings in MRNA
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $408,850,845 | 8,048,245 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $238,332,575 | 8,081,810 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $208,417,361 | 8,068,810 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $217,100,467 | 7,868,810 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $205,321,756 | 7,242,390 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $303,819,280 | 7,306,861 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $482,971,120 | 7,226,861 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $532,768 | 7,972 | Call | Defined | 2024-11-14 | |
| 2024-06-30 | $736,725 | 6,204 | Call | Defined | 2024-08-14 | |
| 2024-06-30 | $858,189,743 | 7,226,861 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $780,210,688 | 7,321,797 | Shares | Defined | 2024-05-14 | |
| 2024-03-31 | $153,446,400 | 1,440,000 | Call | Defined | 2024-05-14 | |
| 2023-12-31 | $730,903,398 | 7,349,456 | Shares | Defined | 2024-02-13 | |
| 2023-12-31 | $200,292,300 | 2,014,000 | Call | Defined | 2024-02-13 | |
| 2023-09-30 | $712,454,342 | 6,897,612 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $758,949,628 | 6,246,499 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $938,747,613 | 6,112,434 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,052,368,073 | 5,858,858 | Shares | Defined | 2023-02-10 | |
| 2022-12-31 | $50,652,840 | 282,000 | Call | Defined | 2023-02-10 | |
| 2022-09-30 | $710,021,009 | 6,004,406 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $907,726,897 | 6,354,406 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,091,601,284 | 6,336,940 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,275,531,752 | 5,022,174 | Shares | Defined | 2022-05-26 | |
| 2021-09-30 | $1,522,919,498 | 3,957,074 | Shares | Sole | 2022-05-26 | |
| 2021-06-30 | $1,426,811,717 | 6,072,056 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $825,254,232 | 6,302,056 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $558,256,130 | 5,343,698 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $541,448,193 | 7,652,978 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $548,797,668 | 8,546,919 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $267,481,023 | 8,930,919 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||